Detalle Publicación

EDITORIAL

For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity

Autores: Marquez-Rodas, I. (Autor de correspondencia); Aznar Gómez, María Ángela; Calles, A.; Melero Bermejo, Ignacio
Título de la revista: CLINICAL CANCER RESEARCH
ISSN: 1078-0432
Volumen: 25
Número: 4
Páginas: 1127 - 1129
Fecha de publicación: 2019
Resumen:
Intratumoral immunotherapy can potentially modulate the tumor microenvironment (TME) and potentiate the effects of concomitant or sequential systemic immunotherapies. Intratumoral administration of different Toll-like receptor agonists, including TLR4, can potentiate these effects through innate and adaptive immunity connection.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-2690
Impacto:
Google Scholar